Tenet Healthcare (NYSE: THC) COO sells 10,000 shares around $258

Rhea-AI Filing Summary

Tenet Healthcare Corp executive vice president and chief operating officer Lisa Y. Foo reported selling 10,000 shares of Common Stock on 2026-07-29 in an open-market transaction at a weighted average price of $258.03 per share, based on multiple trades between $257.97 and $258.43.

After this sale, Foo directly holds 32,053 shares of Tenet Healthcare Common Stock. The Rule 10b5-1 trading-plan checkbox was not marked, and the insider has undertaken to provide detailed trade-by-trade pricing information upon request to the company, its security holders, or SEC staff.

Insider Trade Summary

Net Seller: 10,000 shares

Net Sell 1 txn

Insider Foo Lisa Y

Role EVP, Chief Operating Officer

Sold 10,000 shs ($2.58M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	10,000	$258.03	$2.58M

Holdings After Transaction: Common Stock — 32,053 shares (Direct)

Footnotes (1)

1. F1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $257.97 to $258.43. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 10,000 shares Weighted average sale price: $258.03 per share Sale price range: $257.97–$258.43 per share +1 more

4 metrics

Shares sold 10,000 shares Common Stock sale on 2026-07-29 by EVP and COO Lisa Y. Foo

Weighted average sale price $258.03 per share Aggregate price for 10,000-share open-market sale on 2026-07-29

Sale price range $257.97–$258.43 per share Range of individual trade prices comprising the reported weighted average

Shares owned after sale 32,053 shares Directly held Tenet Healthcare Common Stock following the 2026-07-29 transaction

Key Terms

weighted average sales price, open market or private transaction, Securities and Exchange Commission

3 terms

weighted average sales price financial

"The price is the weighted average sales price of the aggregate"

open market or private transaction financial

"Transaction code description: Sale in open market or private transaction"

Securities and Exchange Commission regulatory

"staff of the Securities and Exchange Commission, upon request"

A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/31/2026 - 08:00 PM Accepted by SEC EDGAR 07/31/2026 - 08:00 PM Learn about SEC filing dates

FAQ

What insider transaction did Tenet Healthcare (THC) report for Lisa Y. Foo?

Tenet Healthcare (THC) reported that EVP and COO Lisa Y. Foo sold 10,000 shares of Common Stock on 2026-07-29. The sale was executed as an open-market transaction at a weighted average price of $258.03 per share.

At what price did Lisa Y. Foo sell Tenet Healthcare (THC) shares?

Lisa Y. Foo sold Tenet Healthcare (THC) shares at a weighted average price of $258.03 per share. According to the disclosure, the individual trades occurred in multiple transactions at prices ranging from $257.97 to $258.43 per share.

How many Tenet Healthcare (THC) shares does Lisa Y. Foo own after this sale?

Following the reported sale, Lisa Y. Foo directly owns 32,053 shares of Tenet Healthcare (THC) Common Stock. This post-transaction holding reflects her remaining direct ownership after disposing of 10,000 shares in the 2026-07-29 open-market transaction.

Was Lisa Y. Foo’s Tenet Healthcare (THC) share sale under a Rule 10b5-1 plan?

The Rule 10b5-1 checkbox for this Tenet Healthcare (THC) report was not marked, so the transaction was not affirmatively identified as being made under a pre-arranged Rule 10b5-1 trading plan.

How is the reported sale price for Tenet Healthcare (THC) shares calculated?

The reported price of $258.03 per Tenet Healthcare (THC) share is a weighted average sales price across multiple trades. The underlying transactions occurred at prices between $257.97 and $258.43, and detailed breakdowns are available upon request.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foo Lisa Y

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TEXAS 75254

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/29/2026		S		10,000	D	$258.03(1)	32,053	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $257.97 to $258.43. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

	Chad J. Wiener, as Attorney-in-fact for Lisa Y. Foo	07/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)